Awakn Life Sciences
Biotechnology ResearchEngland, United Kingdom2-10 Employees
Awakn Life Sciences is a London-based biotechnology research company with a small team. The provided description characterizes Solvonis Therapeutics plc as a clinical-stage biopharmaceutical company focused on medicines for addiction and mental health disorders, headquartered in London and listed on the London Stock Exchange main market. Its portfolio targets high-burden neuropsychiatric conditions with unmet need, combining repurposed and novel compounds, with current emphasis on Alcohol Use Disorder and Post-Traumatic Stress Disorder. A recent development noted is the appointment of Water Tower Research to boost US investor reach for Solvonis Therapeutics. The company maintains a web presence at solvonis.com.